ZIMETTI, Francesca
 Distribuzione geografica
Continente #
EU - Europa 6.007
NA - Nord America 4.155
AS - Asia 2.186
SA - Sud America 26
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 12.398
Nazione #
US - Stati Uniti d'America 4.106
IT - Italia 2.984
CN - Cina 1.211
IE - Irlanda 781
SG - Singapore 647
SE - Svezia 561
FI - Finlandia 544
DE - Germania 430
UA - Ucraina 244
TR - Turchia 199
FR - Francia 135
GB - Regno Unito 81
AT - Austria 58
IN - India 51
NL - Olanda 47
CA - Canada 46
CZ - Repubblica Ceca 36
BE - Belgio 30
BR - Brasile 23
HK - Hong Kong 22
ES - Italia 19
CH - Svizzera 16
TH - Thailandia 13
JP - Giappone 11
PL - Polonia 7
RU - Federazione Russa 7
AU - Australia 6
CI - Costa d'Avorio 6
RO - Romania 6
IR - Iran 5
LT - Lituania 5
TW - Taiwan 5
EU - Europa 4
KR - Corea 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
GR - Grecia 3
IL - Israele 3
KZ - Kazakistan 3
AR - Argentina 2
BD - Bangladesh 2
CV - Capo Verde 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CO - Colombia 1
GL - Groenlandia 1
IM - Isola di Man 1
MA - Marocco 1
RS - Serbia 1
SI - Slovenia 1
Totale 12.398
Città #
Dublin 781
Chandler 648
Singapore 516
Santa Clara 461
Beijing 330
Jacksonville 295
Ashburn 241
Milan 229
Rome 225
New York 211
Boardman 203
Dearborn 198
Nanjing 194
Parma 192
Ann Arbor 187
Izmir 184
Princeton 152
Bremen 149
Wilmington 107
Shanghai 95
San Mateo 67
Helsinki 64
Shenyang 56
Nanchang 53
Naples 53
Kunming 52
Vienna 47
Hebei 46
Jinan 45
Bari 44
Grafing 43
Turin 39
Des Moines 38
Seattle 36
Jiaxing 34
Toronto 34
Chicago 33
Hefei 33
Norwalk 33
Bologna 32
Los Angeles 32
Palermo 32
Tianjin 32
Woodbridge 31
Verona 30
Modena 29
Genoa 28
Houston 27
Brussels 25
Guangzhou 25
Pune 23
Florence 21
Brno 20
Munich 20
Pescara 20
Changsha 17
Dallas 17
Marseille 17
Brescia 15
Vicenza 15
Hangzhou 13
Hong Kong 13
Udine 13
Bangkok 12
Brindisi 12
Reggio Emilia 12
Cagliari 11
Frankfurt am Main 11
Mykolayiv 11
Rho 11
Düsseldorf 10
Fremont 10
Ningbo 10
Perugia 10
Piacenza 10
Pisa 10
Venice 10
Zhengzhou 10
Catania 9
Chengdu 9
Formigine 9
Napoli 9
Padova 9
Taizhou 9
Ancona 8
Caserta 8
Legnano 8
Taiyuan 8
Auburn Hills 7
Kocaeli 7
Pavia 7
Redwood City 7
Rockville 7
Abidjan 6
Bergamo 6
Fairfield 6
Istanbul 6
Lugano 6
Ravenna 6
Redmond 6
Totale 7.318
Nome #
ATEROSCLEROSI E MALATTIA DI ALZHEIMER 2.885
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial 118
Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis 114
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease 110
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 100
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 95
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 93
Effetto delle statine sull’efflusso ABCA1 in macrofagi e cellule epatiche 92
Assessment of Cholesterol Efflux Potential of High-Density Lipoprotein after Treatment with Niacin Extended-Release or Fenofibrate 91
Attivita' del Probucolo nell'inibire l'efflusso lipidico cellulare ABCA1-mediato 91
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 90
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects 90
Highly defined 3D printed chitosan scaffolds featuring improved cell growth 90
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM DIABETIC PATIENTS: CLINICAL APPLICATIONS 89
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 88
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 88
Advance diagnostic support in lipidology project: role for phenotipic and functional evaluation of lipoproteins in dyslipidemias 87
Cholesterol efflux capacity of sera from subjects with LCAT deficiency 86
Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages 86
Lercanidipine Reduces Free Cholesterol-Induced Cytotoxicity 86
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 85
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFFNESS IN HEALTHY SUBJECTS 85
Functional pasta consumption in healthy volunteers modulates ABCG1-mediated cholesterol efflux capacity of HDL 84
Polyphenol health effects on cardiovascular and neurodegenerative disorders: A review and meta-analysis 83
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFNESS IN HEALTY SUBJECTS 83
Dislipidemia diabetica e spessore medio-intimale, ruolo del trasporto inverso del colesterolo. 83
Cyclosporine a affects the reverse cholesterol transport from macrophages in vivo 81
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 80
Serum cholesterol efflux capacity and endothelial function in hyperalfalipoproteinemic subjects 80
Pitavastatin Differently Modulates ATP Binding Cassette A1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 79
Biocompatible 3d printed chitosan-based scaffolds containing α-tocopherol showing antioxidant and antimicrobial activity 77
Study of 3D-printed chitosan scaffold features after different post-printing gelation processes 76
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 75
L’ALCALOIDE BERBERINA RIDUCE L’ATTIVITÀ DI ABCA1 NEI MACROFAGI CON UN EFFETTO TRASCRIZIONALE 74
Effect of an innovative pasta enriched with bioactive components and functional probiotics on HDL cholesterol efflux capacity 74
Hydrocortisone directly promotes cholesterol accumulation in macrophages. 74
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 74
Impaired ATP-binding cassette Transporter AI-mediated Sterols Efflux from Oxidized LDL Loaded Macrophages 73
Effetto della mutazione dell’enzima LCAT sull’efflusso cellulare di colesterolo 73
Evaluation of HDL cholesterol efflux capacity (CEC) after consumption of an innovative pasta enriched with bioactive components and functional probiotics 73
Evaluation of serum cholesterol efflux capacity in diabetic compared to healthy subjects 72
Effect of vitamin D deficiency and replacement on serum HDL cholesterol efflux capacity in premenopausal women 72
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus 71
Depletion of Pre-{beta}-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein 71
High density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism. 71
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 70
Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis 69
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 68
Cholesterol efflux from oxidized LDL loaded macrophages 68
La Lercanidipina riduce la tossicita' cellulare indotta dall'accumulo di colesterolo libero 67
New mechanisms for steroid pro-atherogenic action: up regulation of macrophage LDL receptors, down regulation of cholesterol efflux transporters and increase in intracelluar cholesterol stores. 67
Investigation on mechanisms of cholesterol efflux in human monocytes/macrophages THP-1 67
Cholesterol efflux potential of sera from subjects with LCAT deficiency 66
CHOLESTEROL EFFLUX AND CHOLESTEROL LOADING CAPACITY OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 66
Cholesterol efflux capacity and arterial stiffness: data from the brisighella heart study 66
CHOLESTEROL EFFLUX CAPACITY, HDL-C LEVELS AND CORONARY CALCIUM SCORE AMONG THE VERY ELDERLY SUBJECTS 66
VITAMIN D STATUS AND HDL FUNCTIONALITY IN HEALTHY PRE-MENOPAUSAL WOMEN 66
Pitavastatin Differently Modulates ABCA1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 65
IMPAIRED ABCG1-MEDIATED SERUM CHOLESTEROL EFFLUX CAPACITY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS. 65
The natural compound Berberine affects macrophage ABCA1 expression and function at transcriptional level 65
ANTIATHEROSCLEROTIC EFFECTS OF A NEW COMBINATION OF BERBERINE, MONACOLIN K AND MORUS ALBA: IMPROVEMENT OF HDL FUNCTION 65
Impaired ATP-binding Cassette Transporter AI-mediated sterol efflux from oxidized LDL loaded macrophages 64
Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review 64
Dysfunctional high-density lipoproteins in type 2 diabetes mellitus: Molecular mechanisms and therapeutic implications 64
Dual effect of statins on ABCA1-mediated lipid efflux from macrophages and hepatic cells 63
The natural compound berberine positively affects macrophage functions involved in atherogenesis 63
Probucol Inhibition of ATP-Binding Cassette A1-Mediated Cellular Lipid Efflux 62
IN VIVO ACUTE SYSTEMIC INFLAMMATION, INDEPENDENTLY ON THE ETIOLOGY, AFFECTS HDL CHOLESTEROL EFFLUX CAPACITY 62
Newly identified antiatherosclerotic activity of methotrexate and adalimumab: Complementary effects on lipoprotein function and macrophage cholesterol metabolism 62
Cholesterol efflux potential of sera from subjects with LCAT deficiency 61
Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo 61
Dual effect of statins on ABCA1-mediated lipid efflux from macrophages and hepatic cells 61
Effect of an innovative pasta enriched with bioactive components and functional probiotics on HDL cholesterol efflux capacity 61
Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women 61
Probucol inhibits ABCA1-mediated cellular lipids efflux 60
Cholesterol flux between cells and human serum 60
Increased ABCA1-mediated cholesterol efflux potential of sera from ApoAImilano carriers 60
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 60
Flow-Mediated dilation, carotid wall thickness and hdl function in subjects with hyperalphalipoproteinemia 59
EFFECT OF VITAMIN D REPLACEMENT ON SERUM LIPOPROTEIN FUNCTIONALITY IN HEALTHY PRE-MENOPAUSAL WOMEN 59
Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9 59
Modulazione dell'omeostasi del colesterolo da parte di proprotein convertase subtilisin/kexin type 9 (PCSK9) nel macrofago 58
Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability and telomere length in healthy octogenarians 58
The roles of different pathways in the release of cholesterol from macrophages 57
Cholesterol flux between cells and human serum 57
Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits 57
CHOLESTEROL EFFLUX CAPACITY, HDL-C LEVELS AND CORONARY CALCIUM SCORE AMONG THE VERY ELDERLY SUBJECTS 57
Manidipine reduces pro-inflammatory cytokines secretion in human endothelial cells and macrophages. 57
TRASPORTO INVERSO DEL COLESTEROLO: FATTORI DETERMINANTI L’EFFICIENZA DEL PROCESSO 56
IMPROVEMENT OF CELL CHOLESTEROL TRAFFICKING-RELATED LIPOPROTEIN FUNCTIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB 56
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients 56
Vitamin D status and HDL functionality in healthy pre-menopausal women. 56
The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity 56
THE NATURAL COMPOUND BERBERINE AFFECTS MACROPHAGE ABCA1 EXPRESSION AND FUNCTION TROUGH A TRANSCRIPTIONAL EFFECT 55
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITS ATP BINDING CASSETTE TRANSPORTER A1-MEDIATED CHOLESTEROL EFFLUX FROM MACROPHAGES 55
EFFECTS OF LOMITAPIDE TREATMENT ON THREE EUROPEAN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS: FOCUS ON EFFICACY AND ON HDL FUNCTIONALITY 55
Investigation on mechanism of cholesterol efflux in human monocytes/macrophages THP-1 54
Increased ABCA1-Mediated Cholesterol Efflux Potential of Sera From ApoA-IMilano Carriers 54
Cholesterol efflux potential of sera from subjects with LCAT deficiency 54
Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages 54
Totale 9.946
Categoria #
all - tutte 43.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020811 0 0 0 0 0 166 157 39 130 156 70 93
2020/2021886 19 68 45 20 71 103 92 43 204 58 109 54
2021/2022914 68 25 41 43 28 79 78 78 55 68 59 292
2022/20233.080 324 272 171 218 363 291 63 162 978 56 119 63
2023/20242.139 114 135 87 101 151 440 154 146 109 164 188 350
2024/20252.365 223 364 424 326 529 499 0 0 0 0 0 0
Totale 12.748